UGT1A1 and neutropenia: It has been shown that delayed metabolism of SN-38 leads to enhanced irinotecan-induced toxicity and patients with these UGT1A1 genotypes are recognized as a higher risk population for irinotecan toxicity, such as neutropenia or diarrhea [10,11,12].